Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
McKinsey
Colorcon
Express Scripts
Dow

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Elite Labs Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ELITE LABS, and what generic and branded alternatives to ELITE LABS drugs are available?

ELITE LABS has nineteen approved drugs.



Summary for Elite Labs
US Patents:0
Tradenames:12
Ingredients:12
NDAs:19

Drugs and US Patents for Elite Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elite Labs Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 209924-004 Nov 16, 2018 DISCN No No   Start Trial   Start Trial
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-002 Aug 2, 2006 AB RX No No   Start Trial   Start Trial
Elite Labs NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 075274-001 May 26, 1999 AB RX No No   Start Trial   Start Trial
Elite Labs Inc METHADONE HYDROCHLORIDE methadone hydrochloride TABLET;ORAL 210484-002 Aug 2, 2018 AA RX No No   Start Trial   Start Trial
Elite Labs Inc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 209385-001 Jul 2, 2018 AA RX No No   Start Trial   Start Trial
Elite Labs Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076868-003 Aug 4, 2005 AB RX No No   Start Trial   Start Trial
Elite Labs Inc ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 212418-002 Sep 10, 2019 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Dow
McKinsey
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.